1
|
Shevorykin A, Hyland BM, Robles D, Ji M, Vantucci D, Bensch L, Thorner H, Marion M, Liskiewicz A, Carl E, Ostroff JS, Sheffer CE. Tobacco use, trauma exposure and PTSD: a systematic review. Health Psychol Rev 2024:1-32. [PMID: 38711288 DOI: 10.1080/17437199.2024.2330896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2022] [Accepted: 03/11/2024] [Indexed: 05/08/2024]
Abstract
Tobacco use remains one of the most significant preventable public health problems globally and is increasingly concentrated among vulnerable groups, including those with trauma exposure or diagnosed with PTSD. The goal of this systematic review was to update and extend previous reviews. Of the 7224 publications that met the initial criteria, 267 were included in the review. Summary topic areas include conceptual frameworks for the relation between trauma or PTSD and tobacco use; associations between trauma exposure or PTSD and tobacco use; number and type of trauma exposures and tobacco use; PTSD symptoms and tobacco use; Treatment-related studies; and the examination of causal relations. Evidence continues to indicate that individuals exposed to trauma or diagnosed with PTSD are more likely to use tobacco products, more nicotine dependent and less likely to abstain from tobacco even when provided evidence-based treatments than individuals without trauma. The most commonly cited causal association proposed was use of tobacco for self-regulation of negative affect associated with trauma. A small proportion of the studies addressed causality and mechanisms of action. Future work should incorporate methodological approaches and measures from which we can draw causal conclusions and mechanisms to support the development of viable therapeutic targets.
Collapse
Affiliation(s)
- Alina Shevorykin
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Bridget M Hyland
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Daniel Robles
- Department of Psychology, Faculty of Science, University of Alberta, Edmonton, Canada
| | - Mengjia Ji
- Department of Psychology, The City College of New York (CUNY), New York, NY, USA
| | - Darian Vantucci
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Lindsey Bensch
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Hannah Thorner
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Matthew Marion
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Amylynn Liskiewicz
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Ellen Carl
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Jamie S Ostroff
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Christine E Sheffer
- Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| |
Collapse
|
2
|
Rühl F, Lambert M, Rohenkohl A, Kraft V, Daubmann A, Schneider BC, Luedecke D, Karow A, Gallinat J, Leicht G, Schöttle D. Remission with or without comorbid substance use disorders in early psychosis: long-term outcome in integrated care (ACCESS III study). Front Psychol 2023; 14:1237718. [PMID: 38187418 PMCID: PMC10768197 DOI: 10.3389/fpsyg.2023.1237718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 12/04/2023] [Indexed: 01/09/2024] Open
Abstract
Introduction Schizophrenia-Spectrum-Disorders are associated with poor long-term outcome as well as disability and often severely affect the lives of patients and their families often from symptom onset. Up to 70% of first episode psychosis (FEP) patients suffer from comorbid substance use disorders (SUD). We aimed at studying the course of illness in FEP patients within evidence-based care, with and without comorbid SUD, to examine how decreased, remitted or persistent substance use impacted rates of a combined symptomatic and functional long-term recovery compared with patients without SUD. Methods ACCESS III is an integrated care model for FEP or patients in the early phase of non-affective and affective psychotic disorders. Treatment trajectories of patients, who had been in ACCESS care for 1 year, with and without SUD were compared with regard to the course of illness and quality of life using Mixed Model Repeated Measures (MMRM) and recovery rates were compared using binary logistic regression. Change in substance use was coded as either persistent, decreased/remitted or no use. Results ACCESS III was a prospective 1-year study (N = 120) in patients aged 12-29 years. Of these, 74 (61.6%) had a comorbid SUD at admission. There were no group differences regarding the course of illness between patients with or without comorbid SUD or between patients with a substance abuse or substance dependence. The only outcome parameter that was affected by SUD was quality of life, with larger improvement found in the group without substance use (p = 0.05) compared to persistent and remitted users. Using LOCF, 44 patients (48.9%) fulfilled recovery criteria at the endpoint; recovery did not differ based on substance use status. Discussion SUD and especially substance dependence are common in psychotic disorders even in FEP patients. Evidence-based integrated care led to long-term improvement in patients with comorbid SUD and rate of recovery did not differ for patients with substance use.
Collapse
Affiliation(s)
- Friederike Rühl
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Martin Lambert
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Anja Rohenkohl
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Vivien Kraft
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Anne Daubmann
- Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Brooke C. Schneider
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Daniel Luedecke
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Anne Karow
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Jürgen Gallinat
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Gregor Leicht
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Daniel Schöttle
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
3
|
Trovini G, Amici E, Bauco P, Matrone M, Lombardozzi G, Giovanetti V, Kotzalidis GD, De Filippis S. A comprehensive evaluation of adverse childhood experiences, social-emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice. Eur Psychiatry 2023; 66:e77. [PMID: 37702087 PMCID: PMC10594251 DOI: 10.1192/j.eurpsy.2023.2436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Revised: 06/05/2023] [Accepted: 06/29/2023] [Indexed: 09/14/2023] Open
Abstract
BACKGROUND Adverse childhood experiences (ACEs), social-emotional impairments (SEIs), and neurodevelopmental disorders (NDs) are frequent in psychiatric disorders, including substance-use disorders. We aimed to determine the prevalence of ACE, SEI, or ND in individuals with cannabis-use disorder (CUD). We compared individuals with preCUD-onset ACE, SEI, or ND to those without. METHODS We crosssectionally studied 323 inpatients or outpatients with a history of past or current CUD, aged 12-35 years (mean age 22.94 ± 4.79), 64.5% of whom were male. The sample was divided into two groups: the non-premorbid (N = 52) and the premorbid ACE/SEI/ND group (N = 271). Within the premorbid group, further subgroups were based on ACEs, SEI, and NDs. We also analyzed other substance use and psychiatric symptoms/diagnoses based on the non-premorbid-premorbid dichotomy in the CUD sample. RESULTS Pre-CUD ACE-SEI-ND had higher prevalence of bipolar, schizoaffective, borderline personality, and attention-deficit/hyperactivity disorders, and a history of agitation, hallucinations, and self-injury. The ACE group had higher rates of agitation, depression, delusions, hallucinations, eating disorders, and use of cocaine, amphetamines, and hallucinogens than the SEI or ND. Patients in the premorbid group initiated cannabis use at an earlier age, experienced the first comorbid psychiatric episode earlier, and were hospitalized earlier than those in the non- premorbid ACE-SEI-ND group. CONCLUSIONS PreCUD-onset ACE, SEI, or ND conditions in individuals with CUDare linked to earlier onset of comorbid mental illness. Furthermore, ACEs contribute to significant and potentially severe clinical symptoms, as well as the use of substances other than cannabis.
Collapse
Affiliation(s)
| | | | - Piergiorgio Bauco
- Department of Psychiatry, Università Politecnica delle Marche, Ancona, Italy
| | | | | | | | - Georgios D. Kotzalidis
- Clinica Villa Von Siebenthal, Rome, Italy
- NESMOS Department, Sapienza University of Rome, Faculty of Medicine and Psychology, Rome, Italy
| | | |
Collapse
|
4
|
Innate immune tolerance against adolescent intermittent alcohol exposure-induced behavioral abnormalities in adult mice. Int Immunopharmacol 2022; 113:109250. [DOI: 10.1016/j.intimp.2022.109250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Revised: 08/23/2022] [Accepted: 09/09/2022] [Indexed: 11/05/2022]
|
5
|
Oh H, Rajkumar R, Banawa R, Zhou S, Koyanagi A. Illicit and prescription drug use and psychotic experiences among university students in the United States. JOURNAL OF SUBSTANCE USE 2022. [DOI: 10.1080/14659891.2022.2098842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Hans Oh
- Suzanne Dworak Peck School of Social Work, University of Southern California, Los Angeles, California, USA
| | - Ravi Rajkumar
- Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
| | - Rachel Banawa
- The Milken Institute School of Public Health, The George Washington University, Washington, George, USA
| | - Sasha Zhou
- Department of Public Health, Wayne State University, Detroit, Michigan, USA
| | - Ai Koyanagi
- Research and Development Unit, Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Sant Boi de Llobregat, Spain
| |
Collapse
|
6
|
Verdolini N, Borràs R, Sparacino G, Garriga M, Sagué‐Vilavella M, Madero S, Palacios‐Garrán R, Serra M, Forte MF, Salagre E, Aedo A, Salgado‐Pineda P, Salvatierra IM, Sánchez Gistau V, Pomarol‐Clotet E, Ramos‐Quiroga JA, Carvalho AF, Garcia‐Rizo C, Undurraga J, Reinares M, Martinez Aran A, Bernardo M, Vieta E, Pacchiarotti I, Amoretti S. Prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood. Acta Psychiatr Scand 2022; 146:36-50. [PMID: 35170748 PMCID: PMC9305219 DOI: 10.1111/acps.13415] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 01/29/2022] [Accepted: 02/13/2022] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study was aimed at identifying differences in the prodromal symptoms and their duration, risk factors and markers of vulnerability in patients presenting a first episode mania (FEM) or psychosis (FEP) with onset in late adolescence or adulthood in order to guide tailored treatment strategies. METHODS Patients with a FEM or FEP underwent a clinical assessment. Prodromes were evaluated with the Bipolar Prodrome Symptom Scale-Retrospective (BPSS-R). Chi-squared tests were conducted to assess specific prodromal symptoms, risk factors or markers of vulnerability between groups. Significant prodromal symptoms were entered in a stepwise forward logistic regression model. The probabilities of a gradual versus rapid onset pattern of the prodromes were computed with logistic regression models. RESULTS The total sample included 108 patients (FEM = 72, FEP = 36). Social isolation was associated with the prodromal stage of a FEP whilst Increased energy or goal-directed activity with the prodrome to a FEM. Physically slowed down presented the most gradual onset whilst Increased energy presented the most rapid. The presence of obstetric complications and difficulties in writing and reading during childhood were risk factors for FEP. As for markers of vulnerability, impairment in premorbid adjustment was characteristic of FEP patients. No specific risk factor or marker of vulnerability was identified for FEM. CONCLUSION Early characteristics differentiating FEP from FEM were identified. These findings might help shape early identification and preventive intervention programmes.
Collapse
Affiliation(s)
- Norma Verdolini
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Roger Borràs
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Giulio Sparacino
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Department of Health SciencesUniversità degli Studi di MilanoMilanItaly
| | - Marina Garriga
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Maria Sagué‐Vilavella
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Santiago Madero
- Barcelona Clinic Schizophrenia UnitInstitute of NeurosciencesUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Roberto Palacios‐Garrán
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,University Hospital Santa MariaUniversity of LleidaLleidaSpain
| | - Maria Serra
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Maria Florencia Forte
- Barcelona Clinic Schizophrenia UnitInstitute of NeurosciencesUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Estela Salagre
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Alberto Aedo
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Bipolar Disorders UnitDepartment of PsychiatrySchool of MedicinePontificia Universidad Católica de ChileSantiagoChile
| | - Pilar Salgado‐Pineda
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
| | - Irene Montoro Salvatierra
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Hospital Universitari Institut Pere MataInstitut d'Investigació Sanitària Pere Virgili (IISPV)Universitat Rovira i VirgiliReusSpain
| | - Vanessa Sánchez Gistau
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Hospital Universitari Institut Pere MataInstitut d'Investigació Sanitària Pere Virgili (IISPV)Universitat Rovira i VirgiliReusSpain
| | - Edith Pomarol‐Clotet
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,FIDMAG Germanes Hospitalàries Research FoundationBarcelonaSpain
| | - Josep Antoni Ramos‐Quiroga
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Group of PsychiatryMental Health and AddictionsVall d’Hebron Research Institute (VHIR)BarcelonaSpain,Psychiatric Genetics UnitVall d’Hebron Research Institute (VHIR)BarcelonaSpain,Department of Psychiatry and Legal MedicineUniversitat Autònoma de BarcelonaBarcelonaSpain
| | - Andre F. Carvalho
- The IMPACT (Innovation in Mental and Physical Health and Clinical Treatment) Strategic Research CentreSchool of MedicineBarwon HealthDeakin UniversityGeelongVictoriaAustralia
| | - Clemente Garcia‐Rizo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Barcelona Clinic Schizophrenia UnitInstitute of NeurosciencesUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Juan Undurraga
- Department of Neurology and PsychiatryFaculty of MedicineClinica Alemana Universidad del DesarrolloSantiagoChile,Early Intervention ProgramInstituto Psiquiátrico Dr. J. Horwitz BarakSantiagoChile
| | - María Reinares
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Anabel Martinez Aran
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Miguel Bernardo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Barcelona Clinic Schizophrenia UnitInstitute of NeurosciencesUniversity of BarcelonaIDIBAPSBarcelonaSpain
| | - Eduard Vieta
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Isabella Pacchiarotti
- Bipolar and Depressive Disorders UnitInstitute of NeuroscienceHospital ClinicUniversity of BarcelonaIDIBAPSBarcelonaSpain,Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain
| | - Silvia Amoretti
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM)BarcelonaSpain,Group of PsychiatryMental Health and AddictionsVall d’Hebron Research Institute (VHIR)BarcelonaSpain,Psychiatric Genetics UnitVall d’Hebron Research Institute (VHIR)BarcelonaSpain,Department of Psychiatry and Legal MedicineUniversitat Autònoma de BarcelonaBarcelonaSpain
| |
Collapse
|
7
|
Systematic review of pathways to care in the U.S. for Black individuals with early psychosis. NPJ SCHIZOPHRENIA 2021; 7:58. [PMID: 34857754 PMCID: PMC8639758 DOI: 10.1038/s41537-021-00185-w] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Accepted: 11/03/2021] [Indexed: 11/09/2022]
Abstract
The pathway to receiving specialty care for first episode psychosis (FEP) among Black youth in the US has received little attention despite documented challenges that negatively impact engagement in care and clinical outcomes. We conducted a systematic review of US-based research, reporting findings related to the pathway experiences of Black individuals with FEP and their family members. A systematic search of PubMed, PsycInfo, and Embase/Medline was performed with no date restrictions up to April 2021. Included studies had samples with at least 75% Black individuals and/or their family members or explicitly examined racial differences. Of the 80 abstracts screened, 28 peer-reviewed articles met the inclusion criteria. Studies were categorized into three categories: premordid and prodromal phase, help-seeking experiences, and the duration of untreated psychosis (DUP). Compounding factors such as trauma, substance use, and structural barriers that occur during the premorbid and prodromal contribute to delays in treatment initiation and highlight the limited use of services for traumatic childhood experiences (e.g., sexual abuse). Studies focused on help-seeking experiences demonstrated the limited use of mental health services and the potentially traumatic entry to services (e.g., law enforcement), which is associated with a longer DUP. Although the majority of studies focused on help-seeking experiences and predictors of DUP, findings suggests that for Black populations, there is a link between trauma and substance use in the pathway to care that impacts the severity of symptoms, initiation of treatment, and DUP. The present review also identifies the need for more representative studies of Black individuals with FEP.
Collapse
|